Joel Greenblatt fit · Magic Formula — ROIC alto + EV/EBIT barato
Is Gyre Therapeutics, Inc. Common Stock (GYRE) a Joel Greenblatt Stock?
Partial match — either cheap or high-quality, but not both.
47/100
DSeñales mixtas
1/5 criterios cumplidos
Los criterios de Joel Greenblatt, aplicados a GYRE
EBIT/EV yield ≥ 10%
clave1.7%
ROIC ≥ 25%
clave11.7%
EV/EBIT ≤ 12
57.2x
Gross margin ≥ 30%
95.5%
Cómo se valora GYRE en otras estrategias
Datos financieros en vivo
Cap. mercado
$731.67M
PER (TTM)
55.7x
ROIC (TTM)
11.69%
Margen bruto
95.48%
Preguntas frecuentes
What is GYRE's Joel Greenblatt fit score?
GYRE scores 47/100 on our Joel Greenblatt fit engine — grade D. Partial match — either cheap or high-quality, but not both.
Does Joel Greenblatt actually own GYRE?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends GYRE.
How often is this score updated?
GYRE's Joel Greenblatt fit score is recomputed daily from the latest TTM financials.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Joel Greenblatt posea o recomiende GYRE personalmente.